Specialty code 390200000X · Washington, DC
NPI
1538884184
Since 2022
Specialty
Specialty code 390200000X
Code 390200000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3800 Reservoir Rd NW
Washington, DC, 20007
Phone (202) 444-2000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.7M
1,695 prescriptions
Company payments, 2025
$1,357
From 11 companies
Medicare prescription drug claims, 2024
In 2024, the drug Gonul D Ozay prescribed most often to Medicare patients was Rytary (Carbidopa/Levodopa), with 307 prescriptions and refills. In total Gonul D Ozay wrote 1,695 Medicare prescriptions that cost $2.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-31.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Rytary Carbidopa/Levodopa | 307 | 661 | 94 | $435K |
| Rivastigmine Generic | 169 | 402 | 65 | $53K |
| Rasagiline Mesylate Generic | 151 | 411 | 59 | $35K |
| Nuplazid Pimavanserin Tartrate | 142 | 195 | 26 | $1.0M |
| Nourianz Istradefylline | 129 | 221 | 29 | $407K |
| Escitalopram Oxalate Generic | 84 | 229 | 35 | $1,811 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 82 | 206 | 37 | $2,655 |
| Donepezil Hcl Generic | 64 | 184 | 27 | $1,152 |
| Gocovri Amantadine Hcl | 52 | 96 | 13 | $274K |
| Memantine Hcl Generic | 48 | 98 | 17 | $3,147 |
| Droxidopa Generic | 35 | 72 | Under 11 | $65K |
| Fludrocortisone Acetate Generic | 32 | 70 | 12 | $771 |
| Quetiapine Fumarate Generic | 28 | 58 | 12 | $140 |
| Pyridostigmine Bromide Generic | 20 | 37 | Under 11 | $919 |
| Duloxetine Hcl Generic | 19 | 57 | Under 11 | $641 |
Brand drugs: 810 claims; generic drugs: 885 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gonul D Ozay $1,357 ($1,357 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $322.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 20 | $322 |
| Abbott Laboratories ABT | 6 | $304 |
| Neurocrine BioSciences, Inc. NBIX | 8 | $203 |
| Teva Pharmaceuticals USA, Inc. TEVA | 6 | $155 |
| MDD US Operations, LLC | 1 | $116 |
| Amneal Pharmaceuticals LLC AMRX | 4 | $74.51 |
| Merz Pharmaceuticals, LLC | 3 | $61.54 |
| ACADIA Pharmaceuticals Inc ACAD | 2 | $49.65 |
| Eisai Inc. 4523.T | 2 | $33.48 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $20.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.